2013 Swansea measles epidemic

From WikiMD's WELLNESSPEDIA

The 2013 Swansea measles epidemic was a significant outbreak of measles that occurred in Swansea, Wales, primarily affecting children and young adults. The epidemic highlighted the consequences of declining vaccination rates and raised public health concerns about vaccine-preventable diseases.

Background[edit]

The outbreak was largely attributed to a drop in the uptake of the MMR vaccine (measles, mumps, and rubella) following a now-discredited study published in 1998 by Andrew Wakefield, which falsely linked the vaccine to autism. This led to a significant decrease in vaccination rates in the UK and other parts of the world.

Timeline of the Epidemic[edit]

The epidemic began in November 2012 and peaked in April 2013. By the end of the outbreak in July 2013, over 1,200 cases of measles had been reported in the Swansea area. The outbreak primarily affected children and teenagers who had not received the MMR vaccine.

Public Health Response[edit]

In response to the outbreak, public health officials launched a vaccination campaign to increase MMR vaccine coverage. Clinics were set up in schools and community centers to provide vaccinations to unvaccinated children and young adults. The campaign was successful in increasing vaccination rates and eventually brought the outbreak under control.

Impact[edit]

The epidemic resulted in one death and several hospitalizations. It underscored the importance of maintaining high vaccination coverage to prevent outbreaks of vaccine-preventable diseases. The outbreak also led to increased public awareness about the safety and efficacy of vaccines.

Lessons Learned[edit]

The 2013 Swansea measles epidemic served as a reminder of the importance of herd immunity and the risks associated with declining vaccination rates. It highlighted the need for effective public health communication to counter misinformation about vaccines.

Also see[edit]

Template:Measles outbreaks


Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Medical weight loss NYC | Affordable GLP-1 injections NYC | Budget GLP-1 weight loss shots Philadelphia | New Jersey medical weight loss | NYC medical weight loss | Philadelphia medical weight loss | Sleep clinic NYC | W8MD's Philadelphia GLP-1 doctor | Weight loss prescriptions NYC

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.